354 related articles for article (PubMed ID: 28414107)
1. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method.
Ho PL; Yau CY; Ho LY; Lai EL; Liu MC; Tse CW; Chow KH
Anaerobe; 2017 Oct; 47():51-56. PubMed ID: 28414107
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong, 2020-2021.
Fang H; Li X; Yan MK; Tong MK; Chow KH; Cheng VC; Ho PL
Anaerobe; 2023 Aug; 82():102756. PubMed ID: 37429411
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia.
Shilnikova II; Dmitrieva NV
Anaerobe; 2015 Feb; 31():15-8. PubMed ID: 25157873
[TBL] [Abstract][Full Text] [Related]
5. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility of clinical isolates of Bacteroides fragilis group organisms recovered from 2009 to 2012 in a Korean hospital.
Yim J; Lee Y; Kim M; Seo YH; Kim WH; Yong D; Jeong SH; Lee K; Chong Y
Ann Lab Med; 2015 Jan; 35(1):94-8. PubMed ID: 25553287
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
8. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
Byun JH; Kim M; Lee Y; Lee K; Chong Y
Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
[TBL] [Abstract][Full Text] [Related]
10. Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry.
Nagy E; Maier T; Urban E; Terhes G; Kostrzewa M;
Clin Microbiol Infect; 2009 Aug; 15(8):796-802. PubMed ID: 19438622
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
Ferløv-Schwensen SA; Sydenham TV; Hansen KCM; Hoegh SV; Justesen US
Int J Antimicrob Agents; 2017 Oct; 50(4):552-556. PubMed ID: 28666749
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
[TBL] [Abstract][Full Text] [Related]
13. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antimicrobial resistance among clinical isolates of Bacteroides fragilis group in Canada in 2010-2011: CANWARD surveillance study.
Karlowsky JA; Walkty AJ; Adam HJ; Baxter MR; Hoban DJ; Zhanel GG
Antimicrob Agents Chemother; 2012 Mar; 56(3):1247-52. PubMed ID: 22203594
[TBL] [Abstract][Full Text] [Related]
15. Species differentiation of Bacteroides dorei from Bacteroides vulgatus and Bacteroides ovatus from Bacteroides xylanisolvens - back to basics.
Pedersen RM; Marmolin ES; Justesen US
Anaerobe; 2013 Dec; 24():1-3. PubMed ID: 23994205
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007).
Snydman DR; Jacobus NV; McDermott LA; Golan Y; Hecht DW; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rihs JD; Yu VL; Venezia R; Finegold SM; Rosenblatt JE; Gorbach SL
Clin Infect Dis; 2010 Jan; 50 Suppl 1():S26-33. PubMed ID: 20067390
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of tigecycline against Bacteroides species.
Betriu C; Culebras E; Gómez M; Rodríguez-Avial I; Picazo JJ
J Antimicrob Chemother; 2005 Aug; 56(2):349-52. PubMed ID: 15951353
[TBL] [Abstract][Full Text] [Related]
19. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
Fernández-Canigia L; Litterio M; Legaria MC; Castello L; Predari SC; Di Martino A; Rossetti A; Rollet R; Carloni G; Bianchini H; Cejas D; Radice M; Gutkind G;
Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation of multidrug-resistant Bacteroides isolates from Hungarian clinical samples.
Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Melegh SZ; Latkóczy K; Urbán E
J Glob Antimicrob Resist; 2018 Jun; 13():65-69. PubMed ID: 29101081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
